JPMorgan Chase & Co. Raises Stake in Oric Pharmaceuticals, Inc. $ORIC
JPMorgan Chase & Co. increased its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 3,646.1% during the 2nd quarter, according to the company in its most recent 13F filing with...